Earnings Alerts

Surge in Largan Precision (3008) Earnings: April Sales Reach NT$3.46B, Indicating a 20.4% Increase

  • Largan reported sales in April 2024 of NT$3.46 billion.
  • This represents a 20.4% increase in sales compared to the previous period.
  • Out of the 25 ratings received, 23 recommended a “buy”, 2 recommended a “hold”, and none recommended a “sell”.

A look at Largan Precision Smart Scores

FactorScoreMagnitude
Value4
Dividend3
Growth3
Resilience5
Momentum2
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

When looking at the Smartkarma Smart Scores for Largan Precision, the company showcases strength in several key areas. With a high Resilience score of 5, Largan Precision is well-positioned to weather market fluctuations and adapt to changing circumstances. This indicates the company’s ability to maintain stability and effectively navigate challenges in the long run. Additionally, the company’s strong Value score of 4 suggests that Largan Precision‘s stock may be considered undervalued based on its fundamentals, making it an attractive option for investors seeking assets that are potentially priced below their intrinsic value.

Although Largan Precision receives lower scores in Growth and Momentum, scoring 3 and 2 respectively, the company’s overall outlook appears positive. The Growth score of 3 indicates potential for steady expansion and development over time, while the Momentum score of 2 suggests room for improvement in terms of market performance. With a moderate Dividend score of 3, Largan Precision may offer some income opportunities for investors through dividends. Overall, based on the Smartkarma Smart Scores, Largan Precision shows promise for long-term sustainability and potential value appreciation.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars